Healthcare News: Gilead, Encysive, Actellion

Gilead Wins Approval of Treatment for Lung Disease; FDA Delays Encysive Pharmaceutical's Thelin A...  More »

Gilead Wins Approval of Treatment for Lung Disease; FDA Delays Encysive Pharmaceutical's Thelin Again; Gilead's Letaris Will Carry Warning About Lived Side Effects; Switzerland's Actellion Rises as Tracleer Seen as Leading Drug  « Less